Development of monoclonal antibody-based immunoassays for quantification and rapid assessment of dihydroartemisinin contents in antimalarial drugs.

MLA

Ning, Xiangxue, et al. “Development of Monoclonal Antibody-Based Immunoassays for Quantification and Rapid Assessment of Dihydroartemisinin Contents in Antimalarial Drugs.” Journal of Pharmaceutical & Biomedical Analysis, vol. 159, Sept. 2018, pp. 66–72. EBSCOhost, https://doi.org/10.1016/j.jpba.2018.06.051.

APA

Ning, X., Li, W., Wang, M., Guo, S., Tan, G., Wang, B., & Cui, L. (2018). Development of monoclonal antibody-based immunoassays for quantification and rapid assessment of dihydroartemisinin contents in antimalarial drugs. Journal of Pharmaceutical & Biomedical Analysis, 159, 66–72. https://doi.org/10.1016/j.jpba.2018.06.051

Chicago

Ning, Xiangxue, Weizhi Li, Mian Wang, Suqin Guo, Guiyu Tan, Baomin Wang, and Liwang Cui. 2018. “Development of Monoclonal Antibody-Based Immunoassays for Quantification and Rapid Assessment of Dihydroartemisinin Contents in Antimalarial Drugs.” Journal of Pharmaceutical & Biomedical Analysis 159 (September): 66–72. doi:10.1016/j.jpba.2018.06.051.